X, Z., W, Y., Y, W., R, D., C, W., Y, H., & J, L. (2024). Prospects of anti-GD2 immunotherapy for retinoblastoma. Frontiers in immunology, 15, 1499700. https://doi.org/10.3389/fimmu.2024.1499700
Chicago Style (17th ed.) CitationX, Zhang, You W, Wang Y, Dejenie R, Wang C, Huang Y, and Li J. "Prospects of Anti-GD2 Immunotherapy for Retinoblastoma." Frontiers in Immunology 15 (2024): 1499700. https://doi.org/10.3389/fimmu.2024.1499700.
MLA (9th ed.) CitationX, Zhang, et al. "Prospects of Anti-GD2 Immunotherapy for Retinoblastoma." Frontiers in Immunology, vol. 15, 2024, p. 1499700, https://doi.org/10.3389/fimmu.2024.1499700.
Warning: These citations may not always be 100% accurate.